Aptabio Therapeutics (XKRX:293780) 3-Year Revenue Growth Rate : -2.70% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Aptabio Therapeutics 3-Year Revenue Growth Rate?

Aptabio Therapeutics's Revenue per Share for the three months ended in Mar. 2024 was ₩27.31.

During the past 12 months, Aptabio Therapeutics's average Revenue per Share Growth Rate was 1451.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was -2.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was -42.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of Aptabio Therapeutics was -2.70% per year. The lowest was -65.20% per year. And the median was -35.20% per year.

Competitive Comparison of Aptabio Therapeutics's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Aptabio Therapeutics's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptabio Therapeutics's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aptabio Therapeutics's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Aptabio Therapeutics's 3-Year Revenue Growth Rate falls into.

Aptabio Therapeutics 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Aptabio Therapeutics (XKRX:293780) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Aptabio Therapeutics 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Aptabio Therapeutics's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptabio Therapeutics (XKRX:293780) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aptabio Therapeutics Inc (XKRX:293780) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

N/A

Address

13, Heungdeok 1-ro, Giheung-gu, Tower 504, Gyeonggi-do, Yongin-Si, KOR, 16954

Website

http://www.aptabio.com

Aptabio Therapeutics Inc is a South Korean pharmaceutical company involved in discovery and development of selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The product portfolio of the company include Lipofector-Q, Plusfector, Lipofector-EXT, Lipofector-2000, Lipofector-EZ and Lipofector-pMAX.

Aptabio Therapeutics (XKRX:293780) Headlines

No Headlines